Regenerative Medical Technology Group Inc. (RMTG)
OTCMKTS · Delayed Price · Currency is USD
0.0400
+0.0186 (86.92%)
Jul 9, 2026, 12:32 PM EST

RMTG Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-7.93-7.81-5.56-9.81-5.51-12.88
Depreciation & Amortization
0.330.280.220.310.150.04
Other Amortization
2.11.372.133.061.760.89
Asset Writedown & Restructuring Costs
---4.13--
Stock-Based Compensation
---00.010.28
Other Operating Activities
-1.56-0.480-1.52-0.080.26
Change in Accounts Receivable
-0.02-0.0200.03-0.03-0
Change in Inventory
-0.28-0.15-0.01---
Change in Accounts Payable
6.716.154.13.412.521.31
Change in Other Net Operating Assets
-0.01-0.04-0.03-0.02-0.24
Operating Cash Flow
-0.66-0.710.85-0.42-1.11-9.88
Capital Expenditures
-0.92-0.6-0.22-0.39-0.2-
Cash Acquisitions
-----0.67
Investing Cash Flow
-0.92-0.6-0.22-0.39-0.20.67
Long-Term Debt Issued
-1.1---12.4
Total Debt Issued
1.421.1---12.4
Long-Term Debt Repaid
----0.01-0.02-0.25
Total Debt Repaid
----0.01-0.02-0.25
Net Debt Issued (Repaid)
1.421.1--0.01-0.0212.15
Other Financing Activities
----0.3--
Financing Cash Flow
1.421.1--0.31-0.0212.15
Net Cash Flow
-0.16-0.210.64-1.11-1.332.94
Free Cash Flow
-1.58-1.310.64-0.8-1.31-9.88
Free Cash Flow Margin
-24.77%-25.67%15.47%-33.40%-85.78%-2255.99%
Free Cash Flow Per Share
-0.12-0.100.05-0.07-0.11-0.86
Cash Interest Paid
---000
Levered Free Cash Flow
3.364.252.760.590.57-4.74
Unlevered Free Cash Flow
6.737.544.161.591.56-3.93
Change in Working Capital
6.415.944.063.422.491.55